Benutzer: Gast  Login
Dokumenttyp:
journal article 
Autor(en):
Hartung, R; Matzkin, H; Alcaraz, A; Emberton, M; Harving, N; van Moorselaar, J; Elhilali, M; Vallancien, G; ALF-ONE Study Group 
Titel:
Age, comorbidity and hypertensive co-medication do not affect cardiovascular tolerability of 10 mg alfuzosin once daily. 
Abstract:
PURPOSE: We assessed in real-life practice the impact of age, cardiovascular comorbidity and co-medication on the tolerability and efficacy of 10 mg alfuzosin OD in men with lower urinary tract symptoms suggestive of benign prostatic obstruction. MATERIALS AND METHODS: A total of 6,523 men with a mean age of 64.7 years were enrolled in a 6-month open label study of 10 mg alfuzosin OD. They were stratified by age quartile (younger than 60, 60 to 64, 65 to 70 and older than 70 years), comorbidity...    »
 
Zeitschriftentitel:
J Urol 
Jahr:
2006 
Band / Volume:
175 
Heft / Issue:
Seitenangaben Beitrag:
624-8; discussion 628 
Sprache:
eng 
Print-ISSN:
0022-5347 
TUM Einrichtung:
Urologische Klinik und Poliklinik